利福喷丁和异烟肼治疗潜伏性结核病患者中药物代谢酶遗传多态性与药物不良反应的关系。
Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis.
机构信息
Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.
Department of Clinical Laboratory, Changhua Hospital, Changhua 513, Taiwan.
出版信息
Int J Environ Res Public Health. 2019 Dec 27;17(1):210. doi: 10.3390/ijerph17010210.
Abstract
Weekly rifapentine and isoniazid therapy (3HP) is the most frequent treatment for latent tuberculosis infection (LTBI). However, the association between major adverse drug reactions (ADRs) and drug metabolic enzyme single-nucleotide polymorphisms (SNPs) remains unclear. In this study, 377 participants who received the 3HP regimen were recruited and examined for genotyping of CYP5A6, CYP2B6, CYP2C19, CYP2E1, and NAT2 SNPs. In our study, 184 participants (48.4%) developed ADRs. Moreover, CYP2C19 rs4986893 (TT vs. CC+CT, odds ratio [OR] [95% CI]: 2.231 [1.015-4.906]), CYP2E1 rs2070676 (CC vs. CG+GG, OR [95% CI]: 1.563 [1.022-2.389]), and CYP2E1 rs2515641 (CC vs. CT+TT, OR [95% CI]: 1.903 [1.250-2.898]) were associated with ADR development. In conclusion, CYP2C19 and CYP2E1 SNPs may provide useful information regarding ADRs in LTBI patients receiving the 3HP regimen.
摘要
每周利福喷丁和异烟肼疗法（3HP）是治疗潜伏性结核感染（LTBI）最常用的方法。然而，主要药物不良反应（ADR）与药物代谢酶单核苷酸多态性（SNP）之间的关联尚不清楚。在这项研究中，招募了 377 名接受 3HP 方案治疗的参与者，并对 CYP5A6、CYP2B6、CYP2C19、CYP2E1 和 NAT2 SNPs 进行了基因分型检测。在我们的研究中，184 名参与者（48.4%）发生了 ADR。此外，CYP2C19 rs4986893（TT 与 CC+CT，比值比[OR] [95%置信区间]：2.231 [1.015-4.906]）、CYP2E1 rs2070676（CC 与 CG+GG，OR [95%置信区间]：1.563 [1.022-2.389]）和 CYP2E1 rs2515641（CC 与 CT+TT，OR [95%置信区间]：1.903 [1.250-2.898]）与 ADR 发生相关。总之，CYP2C19 和 CYP2E1 SNP 可能为接受 3HP 方案治疗的 LTBI 患者的 ADR 提供有用的信息。
相似文献
1
Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis.利福喷丁和异烟肼治疗潜伏性结核病患者中药物代谢酶遗传多态性与药物不良反应的关系。
Int J Environ Res Public Health. 2019 Dec 27;17(1):210. doi: 10.3390/ijerph17010210.
2
Evaluation of 3 Months of Once-Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection.评价利福喷丁和异烟肼治疗潜伏性结核病感染的 3 个月疗程。
Ann Pharmacother. 2020 May;54(5):457-463. doi: 10.1177/1060028019888855. Epub 2019 Nov 15.
3
Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan.每周一次服用十二剂利福喷汀加异烟肼治疗潜伏性结核感染：台湾的一项多中心随机对照试验
Tuberculosis (Edinb). 2018 Jul;111:121-126. doi: 10.1016/j.tube.2018.05.013. Epub 2018 Jun 7.
4
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.在预防结核病研究中，接受每周一次利福喷汀加异烟肼或每日一次异烟肼治疗潜伏性结核感染的人群中出现的流感样及其他全身性药物反应。
Clin Infect Dis. 2015 Aug 15;61(4):527-35. doi: 10.1093/cid/civ323. Epub 2015 Apr 22.
5
Three months of rifapentine and isoniazid for latent tuberculosis infection in hemodialysis patients: High rates of adverse events.利福喷丁和异烟肼治疗血液透析患者潜伏性结核感染：不良事件发生率高。
J Microbiol Immunol Infect. 2019 Feb;52(1):158-162. doi: 10.1016/j.jmii.2018.05.003. Epub 2018 Jun 2.
6
High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection.在每周 12 剂量异烟肼和利福喷汀治疗潜伏性结核分枝杆菌感染的项目环境中，治疗完成率较高。
Clin Infect Dis. 2017 Oct 1;65(7):1085-1093. doi: 10.1093/cid/cix505.
7
Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan.12剂方案对潜伏性结核感染的影响：台湾地区的治疗完成率及成本效益
Medicine (Baltimore). 2016 Aug;95(34):e4126. doi: 10.1097/MD.0000000000004126.
8
One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: a randomized controlled trial.一个月每日和三个月每周利福喷丁加异烟肼治疗非 HIV 人群潜伏性结核感染的完成率和安全性相当：一项随机对照试验。
Clin Microbiol Infect. 2024 Nov;30(11):1410-1417. doi: 10.1016/j.cmi.2024.06.024. Epub 2024 Jul 10.
9
Hepatotoxicity, efficacy and completion rate between 3 months of isoniazid plus rifapentine and 9 months of isoniazid in treating latent tuberculosis infection: A systematic review and meta-analysis.异烟肼加利福平 3 个月方案与异烟肼 9 个月方案治疗潜伏性结核感染的肝毒性、疗效和完成率：系统评价和荟萃分析。
J Chin Med Assoc. 2021 Nov 1;84(11):993-1000. doi: 10.1097/JCMA.0000000000000605.
10
High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.中文标题：每周利福喷丁加异烟肼治疗中国潜伏结核感染儿童的高完成率：一项单中心研究。
PLoS One. 2021 Jun 11;16(6):e0253159. doi: 10.1371/journal.pone.0253159. eCollection 2021.
引用本文的文献
1
Overlapping of DRESS and Stevens-Johnson syndrome due to first-line antituberculosis drugs: a case report.一线抗结核药物所致中毒性表皮坏死松解症与史蒂文斯-约翰逊综合征重叠：1例报告
Ther Adv Drug Saf. 2025 Jan 24;16:20420986241312484. doi: 10.1177/20420986241312484. eCollection 2025.
2
DRESS syndrome and tuberculosis: Implementation of a desensitization and re-desensitization protocol to recover antituberculosis drugs in a case series at a specialized TB Unit in Lima, Peru.DRESS 综合征与结核病：在秘鲁利马的一个专门结核病单位的病例系列中实施脱敏和再脱敏方案以恢复抗结核药物。
Medicine (Baltimore). 2024 Sep 27;103(39):e39365. doi: 10.1097/MD.0000000000039365.
3
Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships.NAT2、GSTM1和CYP2E1基因多态性对肺结核患者异烟肼及其代谢产物血药浓度的影响以及暴露-反应关系评估。
Front Pharmacol. 2024 Mar 22;15:1332752. doi: 10.3389/fphar.2024.1332752. eCollection 2024.
4
Uptake and Completion of Tuberculosis Preventive Treatment Using 12-Dose, Weekly Isoniazid-Rifapentine Regimen in Bangladesh: A Community-Based Implementation Study.在孟加拉国使用12剂每周一次异烟肼-利福喷丁方案进行结核病预防性治疗的接受情况和完成情况：一项基于社区的实施研究
Trop Med Infect Dis. 2023 Dec 20;9(1):4. doi: 10.3390/tropicalmed9010004.
5
Next-Generation Sequencing and Bioinformatics-Based Protocol for the Full-Length Gene Polymorphism Analysis.基于新一代测序和生物信息学的全长基因多态性分析方案
Pharmgenomics Pers Med. 2022 Nov 8;15:959-965. doi: 10.2147/PGPM.S371709. eCollection 2022.
6
Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy.全血 3 基因标志物作为利福平为基础的结核病预防治疗决策辅助工具。
Clin Infect Dis. 2022 Sep 14;75(5):743-752. doi: 10.1093/cid/ciac003.
7
Genetic polymorphism of the drug-metabolizing enzyme Cytochrome P4502E1 (CYP2E1) in a healthy Saudi population.沙特健康人群中药物代谢酶细胞色素P4502E1（CYP2E1）的基因多态性
Saudi Pharm J. 2021 Nov;29(11):1355-1360. doi: 10.1016/j.jsps.2021.09.013. Epub 2021 Oct 6.
8
Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia.在埃塞俄比亚亚的斯亚贝巴的全非洲麻风病、结核病康复与培训中心，接受高剂量利福喷丁加异烟肼治疗的人类免疫缺陷病毒患者中药物性肝毒性的决定因素。
HIV AIDS (Auckl). 2021 Mar 16;13:307-314. doi: 10.2147/HIV.S300135. eCollection 2021.
9
Role of Militarine in PM-Induced BV-2 Cell Damage. militarin 在 PM 诱导的 BV-2 细胞损伤中的作用。
Neurochem Res. 2021 Jun;46(6):1423-1434. doi: 10.1007/s11064-021-03281-6. Epub 2021 Mar 6.
10
Impact of Age on Outcome of Rifapentine-Based Weekly Therapy for Latent Tuberculosis Infection.年龄对利福平为基础的每周疗法治疗潜伏性结核病感染结局的影响。
Clin Infect Dis. 2021 Sep 7;73(5):e1064-e1071. doi: 10.1093/cid/ciaa1741.
本文引用的文献
1
Impact of Long Non-Coding RNA Genetic Variants on the Susceptibility and Clinicopathologic Characteristics of Patients with Urothelial Cell Carcinoma.长链非编码RNA基因变异对尿路上皮细胞癌患者易感性及临床病理特征的影响
J Clin Med. 2019 Feb 26;8(3):282. doi: 10.3390/jcm8030282.
2
Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.与其他标准潜伏结核感染治疗方案相比，3 个月每周利福喷丁和异烟肼的成本效益：决策分析研究。
J Antimicrob Chemother. 2019 Jan 1;74(1):218-227. doi: 10.1093/jac/dky403.
3
Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine.在多替拉韦与每周一次异烟肼和利福喷汀药物相互作用研究中细胞因子介导的全身性药物不良反应。
Clin Infect Dis. 2018 Jul 2;67(2):193-201. doi: 10.1093/cid/ciy082.
4
Isoniazid metabolism and hepatotoxicity.异烟肼代谢与肝毒性。
Acta Pharm Sin B. 2016 Sep;6(5):384-392. doi: 10.1016/j.apsb.2016.07.014. Epub 2016 Aug 3.
5
Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan.12剂方案对潜伏性结核感染的影响：台湾地区的治疗完成率及成本效益
Medicine (Baltimore). 2016 Aug;95(34):e4126. doi: 10.1097/MD.0000000000004126.
6
Pharmacogenomics in the clinic.临床中的药物基因组学。
Nature. 2015 Oct 15;526(7573):343-50. doi: 10.1038/nature15817.
7
Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.对于潜伏性结核感染，每周一次利福喷丁加异烟肼治疗三个月的肝毒性低于每日一次异烟肼治疗九个月。
Int J Tuberc Lung Dis. 2015 Sep;19(9):1039-44, i-v. doi: 10.5588/ijtld.14.0829.
8
Pharmacogenetics of isoniazid-induced hepatotoxicity.异烟肼诱导肝毒性的药物遗传学。
Drug Metab Rev. 2015 May;47(2):222-8. doi: 10.3109/03602532.2014.984070. Epub 2014 Nov 19.
9
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention.接受利福喷汀和异烟肼预防结核病的HIV感染者中依非韦伦的药代动力学和药效学
Clin Infect Dis. 2015 Oct 15;61(8):1322-7. doi: 10.1093/cid/civ464. Epub 2015 Jun 16.
10
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.在预防结核病研究中，接受每周一次利福喷汀加异烟肼或每日一次异烟肼治疗潜伏性结核感染的人群中出现的流感样及其他全身性药物反应。
Clin Infect Dis. 2015 Aug 15;61(4):527-35. doi: 10.1093/cid/civ323. Epub 2015 Apr 22.
Zotero 插件